TW200800953A - Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine - Google Patents

Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine

Info

Publication number: TW200800953A
Authority: TW; Taiwan
Prior art keywords: pyridylmethyl; amino; piperidine; intermediates; preparing substituted
Prior art date: 2002-10-30

Application number

TW096104840A

Other languages

English (en)

Inventor

Mammen Mathai

Wilson Richard

Chen Yan

Dunham Sarah

Hughes Adam

Husfeld Graig

Ji Yu-Hua

Li Li

Mischki Trevor

Stergiades Ioanna

Original Assignee

Theravance Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-30

Filing date

2003-10-23

Publication date

2008-01-01

2003-10-23 Application filed by Theravance Inc filed Critical Theravance Inc

2008-01-01 Publication of TW200800953A publication Critical patent/TW200800953A/zh

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrrole Compounds (AREA)
Hydrogenated Pyridines (AREA)

TW096104840A 2002-10-30 2003-10-23 Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine TW200800953A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US42222902P	2002-10-30	2002-10-30
US48648303P	2003-07-11	2003-07-11

Publications (1)

Publication Number	Publication Date
TW200800953A true TW200800953A (en)	2008-01-01

Family

ID=32314442

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
TW092129422A TWI295669B (en)	2002-10-30	2003-10-23	Substituted 4-amino-1-(pyridylmethyl) piperidine and related compounds
TW096104840A TW200800953A (en)	2002-10-30	2003-10-23	Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
TW092129422A TWI295669B (en)	2002-10-30	2003-10-23	Substituted 4-amino-1-(pyridylmethyl) piperidine and related compounds

Country Status (20)

Country	Link
US (2)	US7285564B2 (zh)
EP (1)	EP1556372B1 (zh)
JP (2)	JP4448492B2 (zh)
KR (1)	KR20050061504A (zh)
AR (1)	AR041855A1 (zh)
AT (1)	ATE363482T1 (zh)
AU (1)	AU2003285100A1 (zh)
BR (1)	BR0315778A (zh)
CA (1)	CA2500800A1 (zh)
DE (1)	DE60314170T2 (zh)
EC (1)	ECSP055762A (zh)
ES (1)	ES2287543T3 (zh)
IS (1)	IS7780A (zh)
MX (1)	MXPA05004507A (zh)
NO (1)	NO20052521L (zh)
PE (1)	PE20040606A1 (zh)
PL (1)	PL376716A1 (zh)
RU (1)	RU2005116239A (zh)
TW (2)	TWI295669B (zh)
WO (1)	WO2004041806A2 (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI295669B (en) *	2002-10-30	2008-04-11	Theravance Inc	Substituted 4-amino-1-(pyridylmethyl) piperidine and related compounds
TW200510298A (en)	2003-06-13	2005-03-16	Theravance Inc	Substituted pyrrolidine and related compounds
JP2007524641A (ja) *	2003-07-11	2007-08-30	セラヴァンス，インコーポレーテッド	置換４−アミノ−１−ベンジルピペリジン化合物
PE20050973A1 (es) *	2003-10-29	2005-11-19	Theravance Inc	Sales de acido naftalen-1,5-disulfonico de un compuesto de 4-amino-1-(piridilmetil)piperidina como antagonistas de receptores muscarinicos
WO2005087722A1 (en) *	2004-03-11	2005-09-22	Theravance, Inc.	Diphenylmethyl compounds useful as muscarinic receptor antagonists
WO2005087763A1 (en) *	2004-03-11	2005-09-22	Theravance, Inc.	Diphenylmethyl compounds useful as muscarinic receptor antagonists
TW200540154A (en) *	2004-06-10	2005-12-16	Theravance Inc	Crystalline form of a substituted pyrrolidine compound
TW200628465A (en) *	2004-10-28	2006-08-16	Theravance Inc	Process for preparing substituted 4-amino-1-(pyridylmethyl) piperidine and related compounds
US7880007B2 (en) *	2004-11-29	2011-02-01	Vertex Pharmaceuticals Incorporated	Bicyclic substituted phenyl piperidine modulators of muscarinic receptors
US7786308B2 (en) *	2005-03-28	2010-08-31	Vertex Pharmaceuticals Incorporated	Muscarinic modulators
BRPI0807615A8 (pt) *	2007-02-23	2017-12-05	Theravance Inc	Compostos de difenilmetil amônico quaternário úteis como antagonistas de receptor muscarínico
WO2009153649A1 (en) *	2008-06-19	2009-12-23	Medichem, S.A.	Process for preparing 3-substituted pyrrolidine compounds
KR20120093859A (ko) *	2009-10-07	2012-08-23	머크 샤프 앤드 돔 코포레이션	베타 ３ 아드레날린 수용체 효능제 및 항무스카린제를 사용하는 조합 요법
US20110281853A1 (en)	2010-05-12	2011-11-17	Rishi Arora	Compositions and methods for treating or preventing atrial fibrillation
US9907767B2 (en)	2010-08-03	2018-03-06	Velicept Therapeutics, Inc.	Pharmaceutical compositions and the treatment of overactive bladder
US9522129B2 (en)	2010-08-03	2016-12-20	Velicept Therapeutics, Inc.	Pharmaceutical Combination
PH12013500221A1 (en) *	2010-08-03	2017-08-23	Altherx Inc	Combinations of beta - 3 adrenergic receptor agonists and muscarinic receptor antagonists for treating overactive bladder
SG11201404776PA (en) *	2012-02-09	2014-09-26	Altherx Inc	Combination of muscarinic receptor antagonists and beta- 3 adrenoceptor agonists for treating overactive bladder
KR20170086659A (ko)	2014-12-03	2017-07-26	벨리셉트 테라퓨틱스, 인크.	하부 요로 증상을 위한 변형 방출형 솔라베그론을 이용한 조성물 및 방법
IL310527A (en)	2015-10-23	2024-03-01	B3Ar Therapeutics Inc	Zwitterion solvegron and its uses

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3192221A (en) *	1961-12-04	1965-06-29	Robins Co Inc A H	4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-pyrrolidinones and 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-thionpyrrolidinones and production thereof
US3192206A (en) *	1961-12-04	1965-06-29	Robins Co Inc A H	4-(omega-aminoalkyl)-3, 3-disubstitutedn-hydrocarbon-2-pyrrolidinones and corresponding-2-thionpyrrolidinones
US3192210A (en) *	1961-12-04	1965-06-29	Robins Co Inc A H	4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-pyrrolidinones and 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-thionpyrrolidinones
GB1593851A (en)	1976-10-27	1981-07-22	Gallardo Antonio Sa	N-(4-piperidyl)-benzamides and pharmaceutical compositions containing them
GB1507462A (en)	1974-03-21	1978-04-12	Gallardo Antonio Sa	N-heterocyclic substituted benzamides methods for their preparation and compositions containing them
US4002766A (en) *	1974-12-26	1977-01-11	A. H. Robins Company, Incorporated	Antiarrhythmia methods
US3984557A (en) *	1974-12-26	1976-10-05	A. H. Robins Company, Incorporated	Antiarrhythmia compositions and methods
GB1575310A (en)	1976-11-16	1980-09-17	Anphar Sa	Piperidine derivatives
GB1574418A (en) *	1976-11-16	1980-09-03	Anphar Sa	Piperidine derivatives
CH628885A5 (en)	1978-01-01	1982-03-31	Anphar Sa	Piperidine derivative
US4594343A (en) *	1984-10-19	1986-06-10	Shanklin Jr James R	1-[(aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl]-α,α-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles
IL76583A (en)	1984-10-19	1988-08-31	Robins Co Inc A H	1-(aminoalkyl)-alpha'alpha-diaryl pyrrolidinyl,piperidino and homopiperidino acetamides and acetonitriles and pharmaceutical compositions containing them
EP0228893A3 (en)	1985-12-20	1990-01-03	A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation)	Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl group in allergy treatment
US4810713A (en) *	1985-12-20	1989-03-07	A. H. Robins Company, Incorporated	Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl groups used in a method for allergy treatment
US5932594A (en) *	1988-11-01	1999-08-03	Pfizer, Inc.	Muscarinic receptor antagonists
US5233053A (en) *	1989-03-17	1993-08-03	Pfizer Inc.	Pyrrolidine derivatives
GB8906166D0 (en)	1989-03-17	1989-05-04	Pfizer Ltd	Therapeutic agents
US5070087A (en) *	1989-05-08	1991-12-03	A. H. Robins Company, Incorporated	Aryl(alkyland alkylene)-N-((phenoxy and phenylthio)alkyl) aminoheterocyclics as cardiovascular, anthihistaminic, antisecretory and antiallergy agents
US5028616A (en) *	1989-09-05	1991-07-02	G. D. Searle & Co.	N-benzylpiperidine amides
US5281601A (en) *	1989-12-12	1994-01-25	Pfizer Inc.	Muscarinic receptor antagonists
GB8928042D0 (en) *	1989-12-12	1990-02-14	Pfizer Ltd	Muscarinic receptor antagonists
GB9000301D0 (en) *	1990-01-06	1990-03-07	Pfizer Ltd	Piperidine & pyrrolidine derivatives
US5486527A (en) *	1990-01-06	1996-01-23	Pfizer Inc.	Anticholinergic agents
US5607950A (en) *	1990-01-06	1997-03-04	Pfizer Inc.	Muscarinic receptor antagonists
AU700837B2 (en) *	1995-04-28	1999-01-14	Banyu Pharmaceutical Co., Ltd.	1,4-di-substituted piperidine derivatives
AU7145996A (en)	1995-10-13	1997-04-30	Banyu Pharmaceutical Co., Ltd.	Substituted heteroaromatic derivatives
PE92198A1 (es)	1996-08-01	1999-01-09	Banyu Pharma Co Ltd	Derivados de 1,4-piperidina disustituida que contienen fluor
EP0999205A4 (en)	1997-07-24	2000-05-31	Mitsubishi Tokyo Pharm Inc	AMINOCYCLOALKAN CONNECTIONS
KR20010024074A (ko)	1997-09-18	2001-03-26	아사이 이페이	이미다졸린 화합물
US6319920B1 (en)	1998-02-27	2001-11-20	Syntex (U.S.A.) Llc	2-arylethyl-(piperidin-4-ylmethyl)amine derivatives
SG80041A1 (en)	1998-06-08	2001-04-17	Advanced Medicine Inc	Muscarinic receptor antagonists
US6693202B1 (en) *	1999-02-16	2004-02-17	Theravance, Inc.	Muscarinic receptor antagonists
ES2165768B1 (es) *	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
CA2392028C (en) *	1999-12-07	2009-08-18	Theravance, Inc.	Carbamate derivatives having muscarinic receptor antagonist activity
UA73543C2 (uk) *	1999-12-07	2005-08-15	Тераванс, Інк.	Похідні сечовини, фармацевтична композиція та застосування похідного при приготуванні лікарського засобу для лікування захворювання, яке опосередковується мускариновим рецептором
HUP0303529A3 (en)	2000-12-22	2008-03-28	Almirall Ag	New quinuclidine carbamate derivatives, process for their preparation and pharmaceutical compositions containing them and their use
SK287414B6 (sk)	2000-12-28	2010-09-07	Laboratorios Almirall, S.A.	Chinuklidínové deriváty a kompozície s ich obsahom
PL370765A1 (en)	2001-12-03	2005-05-30	F.Hoffmann-La Roche Ag	4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
TWI295669B (en)	2002-10-30	2008-04-11	Theravance Inc	Substituted 4-amino-1-(pyridylmethyl) piperidine and related compounds
EP1615881A2 (en)	2003-04-01	2006-01-18	Theravance, Inc.	Diarylmethyl and related compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
TW200510298A (en)	2003-06-13	2005-03-16	Theravance Inc	Substituted pyrrolidine and related compounds
JP2007524641A (ja) *	2003-07-11	2007-08-30	セラヴァンス，インコーポレーテッド	置換４−アミノ−１−ベンジルピペリジン化合物
PE20050973A1 (es)	2003-10-29	2005-11-19	Theravance Inc	Sales de acido naftalen-1,5-disulfonico de un compuesto de 4-amino-1-(piridilmetil)piperidina como antagonistas de receptores muscarinicos
WO2005087763A1 (en)	2004-03-11	2005-09-22	Theravance, Inc.	Diphenylmethyl compounds useful as muscarinic receptor antagonists
WO2005087722A1 (en)	2004-03-11	2005-09-22	Theravance, Inc.	Diphenylmethyl compounds useful as muscarinic receptor antagonists
TW200540154A (en)	2004-06-10	2005-12-16	Theravance Inc	Crystalline form of a substituted pyrrolidine compound
TW200628465A (en)	2004-10-28	2006-08-16	Theravance Inc	Process for preparing substituted 4-amino-1-(pyridylmethyl) piperidine and related compounds

2003
- 2003-10-23 TW TW092129422A patent/TWI295669B/zh not_active IP Right Cessation
- 2003-10-23 TW TW096104840A patent/TW200800953A/zh unknown
- 2003-10-28 PE PE2003001087A patent/PE20040606A1/es not_active Application Discontinuation
- 2003-10-29 DE DE60314170T patent/DE60314170T2/de not_active Expired - Lifetime
- 2003-10-29 US US10/696,464 patent/US7285564B2/en not_active Expired - Lifetime
- 2003-10-29 BR BR0315778-4A patent/BR0315778A/pt not_active IP Right Cessation
- 2003-10-29 MX MXPA05004507A patent/MXPA05004507A/es active IP Right Grant
- 2003-10-29 JP JP2005502211A patent/JP4448492B2/ja not_active Expired - Lifetime
- 2003-10-29 AR ARP030103949A patent/AR041855A1/es unknown
- 2003-10-29 EP EP03779416A patent/EP1556372B1/en not_active Expired - Lifetime
- 2003-10-29 RU RU2005116239/04A patent/RU2005116239A/ru not_active Application Discontinuation
- 2003-10-29 WO PCT/US2003/034444 patent/WO2004041806A2/en not_active Ceased
- 2003-10-29 ES ES03779416T patent/ES2287543T3/es not_active Expired - Lifetime
- 2003-10-29 AT AT03779416T patent/ATE363482T1/de not_active IP Right Cessation
- 2003-10-29 PL PL376716A patent/PL376716A1/pl unknown
- 2003-10-29 AU AU2003285100A patent/AU2003285100A1/en not_active Abandoned
- 2003-10-29 KR KR1020057005627A patent/KR20050061504A/ko not_active Withdrawn
- 2003-10-29 CA CA002500800A patent/CA2500800A1/en not_active Abandoned
2005
- 2005-03-31 IS IS7780A patent/IS7780A/is unknown
- 2005-04-27 EC EC2005005762A patent/ECSP055762A/es unknown
- 2005-05-25 NO NO20052521A patent/NO20052521L/no unknown
2007
- 2007-10-17 US US11/974,982 patent/US8030502B2/en active Active
2009
- 2009-12-16 JP JP2009285737A patent/JP2010059214A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
AR041855A1 (es)	2005-06-01
MXPA05004507A (es)	2005-10-18
ATE363482T1 (de)	2007-06-15
RU2005116239A (ru)	2006-01-27
BR0315778A (pt)	2005-09-06
IS7780A (is)	2005-03-31
DE60314170D1 (de)	2007-07-12
JP4448492B2 (ja)	2010-04-07
JP2010059214A (ja)	2010-03-18
JP2006512408A (ja)	2006-04-13
CA2500800A1 (en)	2004-05-21
US20080091034A1 (en)	2008-04-17
WO2004041806A2 (en)	2004-05-21
PL376716A1 (pl)	2006-01-09
KR20050061504A (ko)	2005-06-22
TW200418833A (en)	2004-10-01
AU2003285100A1 (en)	2004-06-07
US20040122014A1 (en)	2004-06-24
DE60314170T2 (de)	2008-01-24
ECSP055762A (es)	2005-07-06
US8030502B2 (en)	2011-10-04
ES2287543T3 (es)	2007-12-16
US7285564B2 (en)	2007-10-23
PE20040606A1 (es)	2004-09-08
EP1556372A2 (en)	2005-07-27
NO20052521L (no)	2005-05-25
EP1556372B1 (en)	2007-05-30
TWI295669B (en)	2008-04-11
WO2004041806A3 (en)	2004-08-05

Publication	Publication Date	Title
TW200800953A (en)	2008-01-01	Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine
NL1032713A1 (nl)	2007-05-01	Histamine-3-receptorantagonisten.
TW200631594A (en)	2006-09-16	Toll like receptor 3 antagonists, methods and uses
WO2007076070A3 (en)	2007-10-25	Modulators of muscarinic receptors
DE602006007556D1 (de)	2009-08-13	Heteroarylsulfonylstilbene als 5-ht2a-antagonisten
UA99620C2 (en)	2012-09-10	Pyridyl piperidine orexin receptor antagonists
NO20032861L (no)	2003-08-21	Heteroarylurea nevropeptid Y Y5-reseptorantagonister
NO20050429D0 (no)	2005-01-26	Substituert kinolin-CCR5-reseptorantagonister
TW200626563A (en)	2006-08-01	Substituted piperazines as CB1 antagonists
NO20052591L (no)	2005-07-29	Pyridopyrolizin og pyridoindolizinderivater
AU2002352633A1 (en)	2003-03-03	Piperidine compounds for use as orexin receptor antagonist
WO2007027734A3 (en)	2007-05-03	Bicyclic and bridged nitrogen heterocycles
WO2004005262A8 (en)	2005-04-28	New neuropeptide y y5 receptor antagonists
MY162095A (en)	2017-05-31	Method of treating symptoms of hormonal variations
DE60321907D1 (de)	2008-08-14	Tachykininrezeptorantagonisten
WO2007079163A3 (en)	2007-08-30	Prokineticin 1 receptor antagonists
MX2007011848A (es)	2008-04-22	Antagonistas del receptor de procineticina i.
WO2006058294A3 (en)	2007-01-18	Modulators of muscarinic receptors
WO2006023852A3 (en)	2006-08-31	Modulators of muscarinic receptors
IS8377A (is)	2006-03-27	Arýlindenópyridín og arýlindenópyrimidín og notkun þeirra sem mótlyf A2A viðtaka adenósíns
AP2005003196A0 (en)	2005-03-31	Bicyclic piperidine derivatives as antagonists of the CCR1 chemokine receptor.
WO2007014263A3 (en)	2007-10-18	Octahydroisoquinoline compounds as opioid receptor modulators
WO2006058303A3 (en)	2006-12-21	Modulators of muscarinic receptors
PT1861360E (pt)	2010-01-28	Derivados de pirrolidina como antagonistas de receptores h3 de histamina
IS8388A (is)	2006-03-30	Blandan af serótónín endurupptökuhindra og histamín 3 viðtaka mótlyfi, öflugum verka eða hlutaverka